Reference
Thoenes A, et al. Discrepancies Between the Labels of Originator and Generic Pharmaceutical Products: Implications for Patient Safety. Drugs - Real World Outcomes : 22 Apr 2020. Available from: URL: https://doi.org/10.1007/s40801-020-00187-7
Rights and permissions
About this article
Cite this article
Label discrepancies between originator and generic drugs impact safety. Reactions Weekly 1802, 8 (2020). https://doi.org/10.1007/s40278-020-77926-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-77926-x